CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 15 of 48

Rheumatology (Oxford)

Briefs 561–600 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Distribution of white matter hyperintensity in SSc patients: a monocenter, cross-sectional magnetic resonance imaging study

    Cross-sectional studySystemic sclerosis

  2. Rheumatology (Oxford)

    Associations of healthy lifestyle and genetic susceptibility with risks of osteoarthritis: a prospective cohort study

    Cohort studyOsteoarthritis

  3. Rheumatology (Oxford)

    Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis

    Cross-sectional studyMyositis

  4. Rheumatology (Oxford)

    Loneliness and social isolation among middle-aged and older adults with SLE: a single centre cross-sectional study

    Cross-sectional studyLupus & APS

  5. Rheumatology (Oxford)

    An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial

    Randomized controlled trialLupus & APS

  6. Rheumatology (Oxford)

    Advances in JDM: biomarker and MRI sensitivity, outcomes and steroid management in a Dutch national prospective cohort

    Cohort studyPediatric

  7. Rheumatology (Oxford)

    Efficacy and safety of rhGH in juvenile dermatomyositis children with glucocorticoid-related growth failure

    Cohort studyPediatric

  8. Rheumatology (Oxford)

    Clinical features in VEXAS syndrome: a systematic review

    Meta-analysisAutoinflammatory & rare

  9. Rheumatology (Oxford)

    Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab

    Secondary analysisAutoinflammatory & rare

  10. Rheumatology (Oxford)

    Anti-HMGCR myopathy: observed ethnic differences in disease and disease outcomes in New Zealand

    Cohort studyMyositis

  11. Rheumatology (Oxford)

    Patients’ experiences of managing their rare rheumatic disease

    Research articleAcross diseases

  12. Rheumatology (Oxford)

    Bidirectional association of rheumatoid arthritis and inflammatory bowel diseases: a large-scale prospective cohort study

    Cohort studyRA

  13. Rheumatology (Oxford)

    Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study

    Cohort studyAutoinflammatory & rare

  14. Rheumatology (Oxford)

    Comparison of quantitative lung ultrasound scores with automated quantitative CT: to overcome the ultrasound limitations

    Cross-sectional studySystemic sclerosis

  15. Rheumatology (Oxford)

    The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis

    Guideline or statementVasculitis & PMR

  16. Rheumatology (Oxford)

    Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients

    Cohort studyRA

  17. Rheumatology (Oxford)

    A case–control study on autoimmune polyendocrine syndromes in patients with systemic lupus erythematosus

    Research articleLupus & APS

  18. Rheumatology (Oxford)

    Prognosis of essential mixed cryoglobulinemia and connective tissue disease-related cryoglobulinemia after rituximab-induced remission

    Cohort studyVasculitis & PMR

  19. Rheumatology (Oxford)

    When to address fatigue in juvenile idiopathic arthritis during clinical visits based on the JAMAR

    Diagnostic or prognostic studyPediatric

  20. Rheumatology (Oxford)

    Sleep and circadian parameters in Behçet’s syndrome: a comparative analysis using actigraphy and questionnaires

    Cross-sectional studyVasculitis & PMR

  21. Rheumatology (Oxford)

    Automated detection of spinal bone marrow oedema in axial spondyloarthritis: training and validation using two large phase 3 trial datasets

    Diagnostic or prognostic studySpondyloarthritis & PsA

  22. Rheumatology (Oxford)

    Disease modifying anti-rheumatic drug treatment cycles and rates of flare in juvenile idiopathic arthritis—a tale of Sisyphean endeavour?

    Cohort studyPediatric

  23. Rheumatology (Oxford)

    MRI-based patient-specific nomogram for diagnostic risk stratification of patients with early knee OA

    Diagnostic or prognostic studyOsteoarthritis

  24. Rheumatology (Oxford)

    Improving preventive health in inflammatory rheumatic diseases: a randomized controlled trial of an educational video intervention

    Randomized controlled trialAcross diseases

  25. Rheumatology (Oxford)

    Targeting PTGDS inhibits pro-inflammatory fibroblasts associated with skin fibrosis in systemic sclerosis

    Mechanistic studySystemic sclerosis

  26. Rheumatology (Oxford)

    Effect of TNF inhibitors on the risk of cancer recurrence in patients with AS: a nested case-control study

    Case-control studySpondyloarthritis & PsA

  27. Rheumatology (Oxford)

    Efficacy of tocilizumab monotherapy after ultrashort glucocorticoid administration to treat giant cell arteritis: three-year follow-up

    Research articleVasculitis & PMR

  28. Rheumatology (Oxford)

    Higher frequencies of age-associated B-cells in early arthritis are linked to atherosclerosis and immune circuits—a potential role as a biomarker for risk stratification

    Cross-sectional studyRA

  29. Rheumatology (Oxford)

    Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study

    Cohort studyRA

  30. Rheumatology (Oxford)

    Frequency-specific microcurrent improves hand function and Raynaud’s symptoms in scleroderma: results of two pilot studies

    Research articleSystemic sclerosis

  31. Rheumatology (Oxford)

    Single-centre comparison of non-familial, familial and monogenic lupus

    Case-control studyLupus & APS

  32. Rheumatology (Oxford)

    Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicentre study

    Cohort studySpondyloarthritis & PsA

  33. Rheumatology (Oxford)

    Impact of immune checkpoint TIGIT on the activation and function of natural killer cells in rheumatoid arthritis patients

    Mechanistic studyRA

  34. Rheumatology (Oxford)

    NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitors

    Cross-sectional studyRA

  35. Rheumatology (Oxford)

    Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study

    Case-control studySystemic sclerosis

  36. Rheumatology (Oxford)

    Safety of biologic therapy in kidney and liver transplant recipients with systemic inflammatory diseases: a real-world study from Israel

    Cohort studyAcross diseases

  37. Rheumatology (Oxford)

    Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study

    Cohort studySystemic sclerosis

  38. Rheumatology (Oxford)

    Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort

    Cross-sectional studySystemic sclerosis

  39. Rheumatology (Oxford)

    Predicting trajectories of lung function decline in systemic sclerosis–related interstitial lung disease

    Cohort studySystemic sclerosis

  40. Rheumatology (Oxford)

    Predictive factors and clinical outcomes of progressive pulmonary fibrosis in anti-threonyl (PL7) positive anti-synthetase syndrome

    Cohort studyMyositis

All 1,905 Briefs in ExploreShowing Briefs 561–600 of 1,905, newest first